Universal is expected to cure leukemia cells in AIDS
 
Source: Zhejiang Online | Time: March 26, 2009
The United States "Science" magazine published by the end of 2007 had been the field of stem cell research a major achievement, that is, scientists will transform human skin cells can become almost comparable to embryonic stem cells, stem cells, which is expected to avoid the human embryonic stem cell research exist huge ethical controversy and legal problems, so that stem cell research more than one option. This cutting-edge life science research results arising from the new global attention as the expected impact of science and the Nobel Prize peak. Recently, the United States to participate in this study University of Wisconsin-Madison Group headed staff, Yu-Jun-ying of Chinese female scientists back home - Zhejiang Zhuji, called the 12-year absence, parents, and teachers taking the time to call alumni, introduce research progress, encouraged the students to his alma mater. Reporter to take this opportunity to conduct an interview, catch a glimpse of the field of stem cell research made heaven and earth, but also witnessed the extraordinary spirit of female scientists.

To do scientific research must be unbiased

"I think not winning is not important, the key is to the benefit of others." When a reporter congratulated Yu-Jun-British scientific research achievements, she replied very simple. She said that when the results were delivered, more than the authority of the global media, said the study has probably the Nobel Prize, for which she was on the very common attitude.

Yu-Jun-ying introduction, she is now still in the laboratory specializes in "universal cell" of the practical application. "In fact, really hard to do science, we must have intelligence, perseverance, endurance and affordability must, above all to have an unbiased view. Because, in terms of scientific experiments on the process than the results of important scientific experiments always faced with this dilemma: continue to experiment and continually failed to repeat, very often, when the probability of failure at more than 99% chance of success at less than 1%. But in fact, success is relying on the failure of a meeting to promote the. So, I am not winning because feels how successful, it would not because they do not feel that winning and failed. are intended for scientific research through their own research, beneficial to humanity. "Yu-Jun-British interpretation of her" scientific concept. "

So far single Yu-Jun-ying said that to return to their loved ones around to see the thinking of the long-Parent, which are very good true. The meet will give her more focus on in future research.

Leukemia is expected to treat AIDS

Yu-Jun-ying said it would continue to improve the human stem cells, the reorganization of the method, in recent years the work of the target is to have through their own efforts at an early date will be omnipotent cells used in disease treatment, with a means of cell transplantation, overcome heart disease, spinal injuries, defects and other organ diseases difficulties .

Embryonic stem cell research has become today a scientific boom, because of its immense practical value, the scientists competing race, and Yu-Jun-British-led Group to the skin cells into a group of four genes that produce graduates with strong success of embryonic stem cells function in stem cells . Yu-Jun-ying introduction to these "golden touch" as the key gene implanted in the skin cells, skin cells through "direct genetic recombination", you can have the embryonic stem cell function.

Yu-Jun-ying also popular interpretation of the "universal cell" research, on any part of the body cells can, through research into stem cells, while stem cells can transform into any one part of the cell. Research on the application of a very wide range, for example, blood stem cell research, if a range of applications can overcome difficulties, and that AIDS and leukemia and so on will no longer be a terminal illness.

5 ~ 10 years after the practical application of

At present, the use of genetically modified stem cells cultivated from the technology itself has matured, but Yu-Jun-ying said that this technology in the medical field is still in its initial stage, are now discussing the use of these stem cells and transplantation of human organs is still too early to . Foster the use of genetically modified stem cell technology has great potential for development, with the exception of skin cells, scientists can also select other organizations in human cell transformation, and they chose the skin cells, because skin cells are easy to access, easy to cultivate.

For the outcome, she has been referred to as the "me" only "want to solve their own problems." She said: "At present, although we theoretically omnipotent cell research breakthrough has been made, but really have applied to the clinical lot of difficulties, this is the next stage of the main direction of my job. My personal prediction study in the U.S. 5 ~ 10 years later there is some simple practical application. "

Yu-Jun-ying also revealed another major study of its own objectives: the adoption of stem cell research and to study the deeper questions of human aging, "I very much hope that it will be my study of human aging from a huge role."

Does not exclude the possibility of return for research

2008, Yu-Jun-ying to the domestic lectures, she once visited a number of domestic research environment, to that end, a reporter also ask questions of interest to readers: "Do you consider the return to work?"

She was, frankly, do not rule out the possible return, but will not consider, because the continuity of scientific research is very important. She said: "Last year, I visited the home of some laboratories, a fact that some people in order to really develop China's scientific research work to do a lot of things. Can be also found several major problems. Single experiment are the necessary equipment, reagents, producing mostly at abroad, if want to buy at home, it is necessary to the adoption of a declaration approved multiple processes. we all know, the scientific experiments of the time is too valuable. "

Yu-Jun-ying not always eye-catching gently insist their selection. She first came to the United States, the biological sciences major and less popular, a lot of Student Transfer computer, then transfer to another school classmate and finance, or large companies looking for employment, such as Yu-Jun-British insist that this will not be many people down. The home, many parents also ask Yu-Jun-ying, how to help their children select the major, let Chengcai Children, Yu-Jun-British proposals: a person who has only himself to do things really are interested, you can persevere, and continue as long as they can, and must there will be a good result.

Yu-Jun-ying: Born in 1974, Zhuji City Nguyen Tan-Chi village town an ordinary farmer, he studied at the middle school Zhu Station, mae school pool in 1997 after graduating from Beijing University in the United States to study, and obtained a doctorate in 2003 from the United States at the University of Wisconsin Thomson-Madison laboratory work, begin stem cell research. November 20, 2007, she co-operation with the people at the world's top academic journal "Science" magazine published thesis, announced the success of the human skin cells into embryonic stem cells similar to the new "universal cell." The study was described as a landmark breakthrough for stem cell research in the medical field has paved the way widely used.

Embryonic stem cells: embryonic stem cells known as the "universal cell", which can be differentiated skin cells and other tissue cells. But human embryonic stem cell research exist enormous ethical controversy, in many countries has also been prohibited by law. Moreover, from a scientific point of view, involving human embryonic stem cell cloning technology to operate very difficult, the source of eggs is also a problem. In contrast, the use of gene technology "imitation" embryonic stem cells, technology is relatively easy to operate on, the cost will be much lower.